Lab company to pay $3.6M to settle Medicaid fraud allegations

Radeas, a Wake Forest, N.C.-based laboratory, has agreed to pay $3.6 million to resolve allegations it submitted false claims for urine tests to the state’s Medicaid program.

Advertisement

The North Carolina attorney general’s office said in an Oct. 3 news release that Radeas performed presumptive and definitive urine drug tests at the same time, which is not medically necessary. Radeas conducted both tests at the same time without supporting clinical documentation and was reimbursed for Medicaid funds to which it was not entitled. 

The alleged medically unnecessary tests occurred between Jan. 1, 2016, and Sept. 30, 2021, according to the release. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.